Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#167 / 167 Total
ADIL - Adial Pharmaceuticals Inc - Stock Price Chart
TickerADIL [NASD]
CompanyAdial Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.89MEPS (ttm)-6.43
P/E-EPS this Y47.78%
Forward P/E-EPS next Y15.16%
PEG-EPS past 5Y38.36%
P/S-EPS next 5Y-
P/B0.69EPS Q/Q57.01%
Dividend-Sales Q/Q-
Insider Own6.78%Inst Own6.52%
Insider Trans0.00%Inst Trans-
Short Float26.71%EarningsNov 14/b
Analyst Recom1.67Target Price7.50
Avg Volume6.54M52W Range0.76 - 14.00
Apr-22-24 10:00AM EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent (Benzinga)
08:30AM Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office (GlobeNewswire)
Apr-10-24 11:53AM Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today? (InvestorPlace) +106.19%
08:30AM Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder (GlobeNewswire)
Apr-02-24 08:30AM Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update (GlobeNewswire)
Mar-01-24 07:00PM Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds (GlobeNewswire) +59.80%
Feb-28-24 09:30AM Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office (GlobeNewswire) +85.50%
Feb-15-24 09:00AM Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20 (ACCESSWIRE)
Feb-13-24 09:15AM Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office (GlobeNewswire) +8.72%
Jan-18-24 08:30AM Adial Announces Appointment of Tony Goodman as Chief Operating Officer (GlobeNewswire)
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schuyler KevinDirectorSep 29 '23Buy2.747001,918700Oct 03 08:54 AM
1⋯10⋯121314151617
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.